Showing results (601-610 of 611) with videos related to

Sort By:
Pageof 62
Nature Metabolism|April 28, 2022
Dysregulation of macrophage PEPD in obesity determines adipose tissue fibro-inflammation and insulin resistanceV Pellegrinelli, S Rodriguez-Cuenca, C Rouault, et al.
Leukemia Research|May 30, 2001
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent, H P Horny, L Escribano, et al.
Genome Research|May 1, 1997
A 1.1-Mb transcript map of the hereditary hemochromatosis locusD A Ruddy, G S Kronmal, V K Lee, et al.
The British Journal of Dermatology|July 24, 2004
Temozolomide and interferon alpha 2b in metastatic melanoma stage IVE Richtig, R Hofmann-Wellenhof, H Pehamberger, et al.
Human Gene Therapy|May 1, 1999
Immunotherapy of metastatic malignant melanoma by a vaccine consisting of autologous interleukin 2-transfected cancer cells: outcome of a phase I studyS Schreiber, E Kämpgen, E Wagner, et al.
Oncogene|April 28, 2026
Rapid activation of ARF6 after RAF inhibition augments BRAFV600E and promotes therapy resistanceJunhua Wang, Yinshen Wee, Thomas Jacob, et al.
Frontiers in Nephrology|July 4, 2025
The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipientsMario Schiffer, Lars Pape, Julia K Wolff, et al.
Nature Communications|August 4, 2024
Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapyYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancerYinshen Wee, Junhua Wang, Emily C Wilson, et al.
Nature Genetics|August 1, 1996
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosisJ N Feder, A Gnirke, W Thomas, et al.
Pageof 62